Celltrion Healthcare Ranks High in Search... Stock Price -0.13%
As of 10:31 AM on the 8th, Celltrion Healthcare is trading at 148,300 KRW, down 0.13% from the previous day. This represents a 14.28% decline compared to January 11. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners are estimated to have net sold 2,000 shares of Celltrion Healthcare, while institutions have net bought 1,000 shares. Over the past five days, individual investors have net sold 410,915 shares, whereas foreigners and institutions have net bought 224,940 shares and 185,934 shares, respectively.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Jensen Huang: "China Will Eventually Allow Imports of U.S. AI Chips"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
